Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

EF Johnson Technologies, Inc.

Thumbshot of's website
http://www.efjohnsontechnologies.com/

EF Johnson Technologies, Inc. Announces Third Quarter Financial Reporting Date

Wednesday 4th of November 2009 16:48

IRVING, Texas, Nov. 4 /PRNewswire-FirstCall/ -- EF Johnson Technologies, Inc. (Nasdaq: EFJI) announced today that the Company will release the financial results for the quarter ending September 30, 2009, and has scheduled an investor webcast and conference call for 4:30 p.m. Eastern Time on Thursday, November 12, 2009. Michael E. Jalbert, chairman and chief executive officer, and Jana Ahlfinger Bell, executive vice president and chief financial officer, will host the call and discuss EF Johnson Technologies, Inc.'s financial results for the quarter.

The investor conference call will be available via live webcast on the EF Johnson Technologies, Inc. website at www.efjohnsontechnologies.com under the tab "Investor Relations." Investors are advised to go to the website at least 15 minutes prior to the call to register, download and install any necessary audio software. The webcast will be archived for 30 days.

To participate by telephone, the domestic dial-in number is (877) 407-8031 and the international dial-in number is (201) 689-8031. Participants are urged to call in to the conference call at least 10 minutes prior to the start time.

About EF Johnson Technologies, Inc.

Headquartered in Irving, Texas, EF Johnson Technologies, Inc. focuses on innovating, developing and marketing the highest quality secure communications solutions to organizations whose mission is to protect and save lives. The Company's customers include first responders in public safety and public service, the federal government, and industrial organizations. The Company's products are marketed under the EFJohnson, 3e Technologies International, and Transcrypt International names. For more information, visit http://www.EFJohnsonTechnologies.com.

SOURCE EF Johnson Technologies, Inc.


Browse other news from this organisation: EF Johnson Technologies, Inc.

Source PR Newswire

PR Newswire Logo
www.prnewswire.co.uk

Browse news from 2009

Download PDF PDF Version

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.